Antonella Cordoba/LinkedIn
Aug 9, 2026, 15:16
Antonella Cordoba: Emicizumab and the Evolving Landscape of Hemophilia A
Antonella Cordoba, Médica Hematologa at Hospital General de Agudos José Maria Penna, shared a post on LinkedIn:
”The meeting organized by Roche on Hemlibra (emicizumab) and the new advances in the treatment of hemophilia A was very enriching.
A space for updating and exchange on how innovation continues to transform the approach to hemorrhagic diseases.
Thank you Guillermo Rabossi for the invitation and for generating these learning spaces.”

-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments